HIGHLIGHTS
- who: Ario Mirian et al. from the Western University Department of Clinical Neurological Sciences, London Health Sciences Centre, Western University, London, Ontario, Canada have published the research work: Comparison of fixed cell-based assay to radioimmunoprecipitation assay for acetylcholine receptor antibody detection in myasthenia gravis, in the Journal: (JOURNAL)
SUMMARY
Myasthenia gravis (MG) is an antibody-mediated neuromuscular junction disorder characterized by abnormal muscle fatigability that may selectively affect ocular muscles or be more generalized. Approximately 50% of ocular and 85% of generalized MG patients are anti-AChR-positive by radio immunoprecipitation assay . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.